Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population

Meta Gene

Volumn 2, Issue , 2014, Pages 565-578

  Radovica, I ^a   Fridmanis, D ^a   Silamikelis, I ^a   Nikitina Zake, L ^a   Klovins, J ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

Association study; Dyslipidemia; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; Total cholesterol; Triglycerides

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CETP GENE; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HAPLOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MLXIPL GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE;

EID: 84916206303     PISSN: None     EISSN: 22145400     Source Type: Journal    
DOI: 10.1016/j.mgene.2014.07.006     Document Type: Article

References (58)

1. Altman D.G. Practical Statistics for Medical Research 1991, Chapman & Hall/CRC, London. D.G. Altman (Ed.).
2. Aulchenko Y.S., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 2009, 41(1):47-55.
3. Baba K., et al. Validating an alternate version of the chewing function questionnaire in partially dentate patients. BMC Oral Health 2009, 9:9.
4. Barrett J.C. Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009, 2009(10). (p. pdb ip71).
5. Barrett J.C., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
6. Bhagavan N.V. Medical Biochemistry 2002, Harcourt/Academic Press, San Diego, (1016 pp.). 4th ed.
7. Braun, T.R. et al., A replication study of GWAS-derived lipid genes in Asian Indians: the chromosomal region 11q23.3 harbors loci contributing to triglycerides. PLoS One. 7(5), e37056.
8. Burkhardt R., et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler. Thromb. Vasc. Biol. 2008, 28(11):2078-2084.
9. Cai S.J., et al. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989, 28(23):8966-8971.
10. Cairo S., et al. WBSCR14, a gene mapping to the Williams-Beuren syndrome deleted region, is a new member of the Mlx transcription factor network. Hum. Mol. Genet. 2001, 10(6):617-627.
11. Camenisch G., et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J. Biol. Chem. 2002, 277(19):17281-17290.
12. Chasman D.I., et al. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ. Cardiovasc. Genet. 2008, 1(1):21-30.
13. Chen, G.B. et al., Practical and theoretical considerations in study design for detecting gene-gene interactions using MDR and GMDR approaches. PLoS One. 6(2), e16981.
14. Dachet C., et al. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler. Thromb. Vasc. Biol. 2000, 20(2):507-515.
15. Durrington P. Dyslipidaemia. Lancet 2003, 362(9385):717-731.
16. Edmondson, A.C. et al., Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol. Circ. Cardiovasc. Genet. 4(2), 145-155.
17. Franzoso G., et al. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 1992, 359(6393):339-342.
18. Gauderman W., Morrison J. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies http://hydra.usc.edu/gxe.
19. Goldberg A.C.Dyslipidemia (September 2013 [cited 2014 31.01.2014]; Available from:). http://www.merckmanuals.com/professional/endocrine_and_metabolic_disorders/lipid_disorders/dyslipidemia.html.
20. Heid I.M., et al. Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ. Cardiovasc. Genet. 2008, 1(1):10-20.
21. Herman, M.A. et al., A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 484(7394), 333-338.
22. Hiura Y., et al. Identification of genetic markers associated with high-density lipoprotein-cholesterol by genome-wide screening in a Japanese population: the Suita study. Circ. J. 2009, 73(6):1119-1126.
23. Howie B.N., Donnelly P., Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009, 5(6):e1000529.
24. Igl, W., et al., Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet. 6(1), e1000798.
25. Ignatovica V., et al. Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population. Mol. Biol. Rep. 2011, 39(2):1917-1925.
26. Johansen, C.T. et al., Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 42(8), 684-687.
27. Kathiresan S., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 2008, 40(2):189-197.
28. Kathiresan S., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 2009, 41(1):56-65.
29. Kawaguchi T., et al. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(24):13710-13715.
30. Khovidhunkit, W., et al., Resequencing CETP, LIPC and LIPG Genes in Thai Subjects With Hyperalphalipoproteinemia. Am. J. Cardiol.
31. Kooner J.S., et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 2008, 40(2):149-151.
32. Lanktree M.B., et al. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J. Lipid Res. 2009, 50(7):1487-1496.
33. Lou X.Y., et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am. J. Hum. Genet. 2007, 80(6):1125-1137.
34. Ma, L., et al., Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data. BMC Med. Genet. 11, 55.
35. Marcais C., et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 2005, 115(10):2862-2869.
36. Marchini J., et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 2007, 39(7):906-913.
37. Musunuru, K., et al., Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363(23), 2220-2227.
38. Nelis M., et al. Genetic structure of Europeans: a view from the North-East. PLoS One 2009, 4(5):e5472.
39. Pollin T.I., et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008, 322(5908):1702-1705.
40. Purcell S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
41. Radovica I., et al. The association of common SNPs and haplotypes in CETP gene with HDL cholesterol levels in Latvian population. PLoS One 2013, 8(5):e64191.
42. Ridker P.M., et al. Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study. Circ. Cardiovasc. Genet. 2009, 2(1):26-33.
43. Sabatti C., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 2009, 41(1):35-46.
44. Sandhu M.S., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008, 371(9611):483-491.
45. Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316(5829):1331-1336.
46. Shen, H., et al., Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish. Arch. Intern. Med. 170(20), 1850-1855.
47. Soria L.F., et al. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(2):587-591.
48. Suchindran, S., et al., Genome-wide association study of Lp-PLA(2) activity and mass in the Framingham Heart Study. PLoS Genet. 6(4), e1000928.
49. Thompson J.F., et al. Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol. Clin. Genet. 2004, 66(3):223-228.
50. Thompson J.F., et al. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 2005, 181(1):45-53.
51. Thompson J.F., et al. High-density genotyping and functional SNP localization in the CETP gene. J. Lipid Res. 2007, 48(2):434-443.
52. Utermann G., et al. Polymorphism of apolipoprotein E II. Genetics of hyperlipoproteinemia type III. Clin. Genet. 1979, 15(1):37-62.
53. Vance D.E., Vance J.E. Biochemistry of Lipids, Lipoproteins and Membranes 2008, Elsevier, Amsterdam, Boston, (631 pp.). 5th ed.
54. Wallace C., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet. 2008, 82(1):139-149.
55. Waterworth, D.M. et al., Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 30(11), 2264-2276.
56. Willer C.J., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 2008, 40(2):161-169.
57. World Health Organization, H.G.P. Familial hypercholesterolemia: report of a second WHO consultation 1999, WHO, Geneva, (WHO/HGN/FH/Cons/99.2).
58. Wulczyn F.G., Naumann M., Scheidereit C. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature 1992, 358(6387):597-599.